| Product | Code | ||
|---|---|---|---|
| PPAP2A Antibody (C-term) | AP21319b | 400 µl |
Contact us |
| INPP5A Antibody (C-term) | AP21321b | 400 µl |
Contact us |
| NODAL Antibody | AP21320a | 400 µl |
Contact us |
| PTK7 Antibody (N-Term) | AP21298a | 400 µl |
Contact us |
| CNTF Antibody (C-term) | AP21322b | 400 µl |
Contact us |
| ADAM15 Antibody (N-Term) | AP21324a | 400 µl |
Contact us |
| (Mouse) Ctf1 Antibody | AP21323a | 400 µl |
Contact us |
| AMZ1 Antibody (N-Term) | AP21330a | 400 µl |
Contact us |
| TACR1 Antibody (C-term) | AP21328b | 400 µl |
Contact us |
| (Mouse) Utf1 Antibody (C-term) | AP21331b | 400 µl |
Contact us |
| Nodal Antibody | AP21327a | 400 µl |
Contact us |
| Rabbit Anti-CXCL13 Polyclonal Antibody | AP52043 | 100 µl |
Contact us |
Reddot Biotech Inc.
Reddot Biotech Inc., located in Kelowna, British Columbia, Canada, was founded in 2015 by an executive team with over 35 years combined experience in the medical device industry. We focus on providing customers in the global marketplace with timely customer service, reliable supply and products with superior performance. We thrive on competition, innovation and fast resource allocation for customer needs. Reddot Biotech Inc. currently focuses on the sale of reagents and related products for pharmaceutical, laboratory, medical and scientific research use. We are committed to research and development to bring customers top quality products providing accurate, reliable and fast results critical to any research. With extensive experience working with companies and research institutes across continents, we offer tremendous value in the products and services we provide. We do our best to bridge the gap between the industry and academics, and welcome opportunities in collaboration to further scientific research.
More information? E-mail info@divbio.eu
Abcepta
Abcepta is a leading manufacturer of primary antibodies with more than fifteen years of experience. We supply quality antibodies and related products drug discovery and academic laboratories worldwide. Our focus is on targets covering the major research areas impacting health and disease, including cancer, metabolism, cardiovascular, neuroscience, and stem cells.
More information?Contact Us by e-mail info@divbio.eu